CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 190 filers reported holding CRISPR THERAPEUTICS AG in Q2 2019. The put-call ratio across all filers is 1.08 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,312,711 | -49.5% | 50,952 | -37.6% | 0.06% | -45.0% |
| Q2 2023 | $4,581,024 | +78.6% | 81,600 | +256.0% | 0.10% | +40.8% |
| Q3 2021 | $2,565,000 | -56.3% | 22,919 | -36.7% | 0.07% | -62.4% |
| Q2 2021 | $5,866,000 | +2615.7% | 36,234 | +1947.1% | 0.19% | +2262.5% |
| Q1 2021 | $216,000 | -80.0% | 1,770 | -92.3% | 0.01% | -91.8% |
| Q2 2019 | $1,079,000 | – | 22,905 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $31,294,000 | 31.24% |
| NEA Management Company, LLC | 1,590,002 | $365,593,000 | 10.56% |
| Ariose Capital Management Ltd | 37,900 | $2,379,000 | 9.30% |
| ARK Investment Management | 9,404,071 | $590,294,000 | 2.46% |
| NIA IMPACT ADVISORS, LLC | 80,082 | $5,027,000 | 2.44% |
| Nikko Asset Management Americas, Inc. | 4,619,747 | $291,044,000 | 2.14% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,139,000 | 1.98% |
| Integral Health Asset Management, LLC | 120,000 | $7,532,000 | 1.96% |
| Valiant Capital Management, L.P. | 240,683 | $15,108,000 | 1.73% |
| Deuterium Capital Management, LLC | 18,000 | $1,130,000 | 1.45% |